FDA approves first treatment for BCG-unresponsive bladder cancer
The FDA has approved the first therapy for bladder cancer patients unresponsive to BCG treatment. This regulatory action marks a significant milestone in oncology care.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed